Nail fungus is also called onychomycosis. It is among the common conditions that begin as a white either yellow spot under the tip of the fingernail or toenail. Eventually, when the fungal infection goes more extensive, the nail fungus can cause discoloring of the nail, thicken and crumble at the edge. It can affect several nails. In the case of nail fungus causes pain and cause thickened nails, the possible treatment is self-care steps and medications. However, nail fungus often comes back even if treatment is successful.
MARKET DYNAMICS
The Onychomycosis Treatment market is driving due to the increasing awareness regarding dermatophytic onychomycosis among podiatrists and dermatologists, rising prevalence of onychomycosis. However, lack of awareness among the people is expected to hamper the growth of the global onychomycosis treatment market.
MARKET SCOPE
The "Onychomycosis Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of onychomycosis treatment market with detailed market segmentation by treatment type and distribution channel. The onychomycosis treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in onychomycosis treatment market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The onychomycosis treatment market is segmented on the basis of treatment type and distribution channel. Based on treatment type, the market is segmented as oral and topical. On distribution channel, the market is categorized as hospital pharmacies, retail pharmacies, drug stores, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the onychomycosis treatment market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The onychomycosis treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting onychomycosis treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the onychomycosis treatment market in these regions.
MARKET PLAYERS
The report covers key developments in the onychomycosis treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from onychomycosis treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for onychomycosis treatment in the global market. Below mentioned is the list of few companies engaged in the onychomycosis treatment market.
The report also includes the profiles of key players in onychomycosis treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
-Valeant Pharmaceuticals Inc.
-Galderma S.A.
-Novartis AG
-Pfizer, Inc.
-Moberg Pharma AB
-Johnson and Johnson Services, Inc.
-Bayer AG
-Dr. Reddy?s Laboratories Ltd.
-Cipla Ltd.
-Medimetriks Pharmaceuticals, Inc.
The Insight Partner?s dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.